AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2023

Dec 8, 2023

30339_dirs_2023-12-08_38c340d0-a7a1-4538-a723-52d45d7e032a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2023-12-06

Reporting Person: Green Eric Mark (Director, President, CEO and Board Chair)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-12-06	Common Stock	G	9800	$343.00	Disposed	130774.0865	Direct

Footnotes

F1: This transaction represents a charitable gift donation to a private, non-profit educational institution for which Mr. Green received no compensatory benefit